Peli BioThermal has expanded its dry ice shipper options to support “exponential growth” in cell and gene therapy shipments worldwide, as well as the continued need to transport pandemic payloads.

Available parcel sizes range from 1.1 litres to 179 litres and cover temperature ranges of -65°C to -20°C, according to the company.

“Cell and gene therapies are highly individualised and patient-centric, which creates a drastically different supply chain than we see for mass-produced pharmaceutical products,” said Peli BioThermal’s vice president of worldwide new product development and engineering Greg Wheatley.

“This supply chain introduces individuals who are not always familiar with cold chain packaging. Our job is to make easy-to-use temperature controlled solutions for these applications.”

Peli BioThermal said its expanded range of dry ice parcels can replace liquid nitrogen systems on short journeys that include a courier. The parcels are available in single-use ‘Sherpa Systems’ and ‘DeepFreeze’ shippers, as well as the reusable ‘Crēdo Cube’ shippers.

The Sherpa Systems shippers range in size from 5 litres to 179 litres, DeepFreeze products are available in 1.1 litre to 8 litre sizes, and Crēdo Cube shippers include 5 litre and 17 litre sizes.

Sherpa Systems use ‘Expanded Polystyrene’ (EPS) insulation and are molded with density to achieve required performance standards, according to the company. DeepFreeze and Crēdo Cube shippers feature high-performance ‘VIP’ (vacuum insulated panels) that protect the payload and require less dry ice, lowering transportation costs. Dry ice products provide frozen payload protection with durations from 96 hours to 225 hours.

Peli BioThermal said it would continue to work on utilising dry ice in even more platforms to provide solutions for payload protection of temperature sensitive shipments.